Search results
Phase III trial shows donidalorsen cuts attack rate in hereditary angioedema
Medical Xpress· 5 hours agoFor patients with hereditary angioedema, donidalorsen reduces the attack rate, according to a study...
On-demand sebetralstat speeds symptom relief in hereditary angioedema, clinical trial finds
Medical Xpress· 7 hours agoFor patients with type 1 or type 2 hereditary angioedema, sebetralstat provides faster times to...
What’s Wrong With King George in Queen Charlotte? His Illness Lines Up With History
STYLECASTER via Yahoo News· 6 days agoSome medical historians have said that George III’s mental instability was caused by a hereditary...
A Quiet Place: Day One: John Krasinski Explains Why He Chose Pig Director Michael Sarnoski
COMINGSOON.net via Yahoo News· 6 hours agoJohn Krasinski has explained why he chose Pig director Michael Sarnoski for the prequel movie A...
One Deadly Scene In Hereditary Laid The Groundwork For The Entire Horror Movie - SlashFilm
/Film· 1 day agoA particular scene in Ari Aster's "Hereditary," which unfolds around the 33-minute mark, is designed...
Intellia (NTLA) Up on Upbeat Long-Term Angioedema Study Data
Zacks via Yahoo Finance· 3 hours agoIntellia (NTLA) gains 10% after reporting encouraging long-term efficacy data from the phase I...
Could the Duke of Westminster’s wedding change a 300-year-old English law?
The Independent via Yahoo News· 4 days agoHis money comes from his family’s vast property empire, which, in essence, means that he owns half...
Hereditary Angioedema Attacks Reduced With Donidalorsen Prophylaxis
MedPage Today· 5 days agoAn antisense oligonucleotide therapy showed efficacy as a prophylactic treatment for hereditary...
Red Flags for Early-Onset Colorectal Cancer Identified
Medscape· 14 hours agoThe most common presenting signs and symptoms of early-onset colorectal cancer include rectal...
...Donidalorsen Data, Analyst Says Results Show Competitive Hereditary Angioedema Profile - Ionis...
Benzinga· 4 days agoDiscover the results of Ionis Pharmaceuticals' Phase 3 studies on donidalorsen for hereditary...